Literature DB >> 12770924

Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Shereeni J Veerasingham1, Mohan K Raizada.   

Abstract

This review focuses on the dysfunction of the intrinsic brain renin-angiotensin system (RAS) in the pathogenesis of hypertension. Hyperactivity of the brain RAS plays a critical role in mediating hypertension in both humans and animal models of hypertension, including the spontaneously hypertensive rat (SHR). The specific mechanisms by which increased brain RAS activity results in hypertension are not well understood but include increases in sympathetic vasomotor tone and impaired arterial baroreflex function. We discuss the contribution of endogenous angiotensin (Ang) II actions on presympathetic vasomotor rostral ventrolateral medulla neurons to enhance sympathetic activity and maintain hypertension. In addition, we discuss Ang II-induced attenuation of afferent baroreceptor feedback within the nucleus tractus solitarius and its relevance to the development of hypertension. We also outline the cellular and molecular mechanisms of Ang II signal transduction that may be critical for the initiation and establishment of hypertension. In particular, we present evidence for a phosphoinositide-3-kinase-dependent signaling pathway that appears to contribute to hypertension in the SHR, possibly via augmented Ang II-induced increases in neuronal firing rate and enhanced transcriptional noradrenaline neuromodulation. Finally, we outline future directions in utilizing our understanding of the brain RAS dysfunction in hypertension for the development of improved therapeutic intervention in hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770924      PMCID: PMC1573858          DOI: 10.1038/sj.bjp.0705262

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  154 in total

Review 1.  Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata.

Authors:  D B Averill; D I Diz
Journal:  Brain Res Bull       Date:  2000-01-15       Impact factor: 4.077

Review 2.  The physiological role of AT1 receptors in the ventrolateral medulla.

Authors:  T Tagawa; M A Fontes; P D Potts; A M Allen; R A Dampney
Journal:  Braz J Med Biol Res       Date:  2000-06       Impact factor: 2.590

3.  Divergent functions of angiotensin II receptor isoforms in the brain.

Authors:  R L Davisson; M I Oliverio; T M Coffman; C D Sigmund
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

4.  Tissue-specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction.

Authors:  S Clausmeyer; A Reinecke; R Farrenkopf; T Unger; J Peters
Journal:  Endocrinology       Date:  2000-08       Impact factor: 4.736

5.  Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats.

Authors:  M A Fontes; O Baltatu; S M Caligiorne; M J Campagnole-Santos; D Ganten; M Bader; R A Santos
Journal:  Physiol Genomics       Date:  2000-04-27       Impact factor: 3.107

Review 6.  Angiotensin II-mediated vascular smooth muscle cell growth signaling.

Authors:  T Inagami; S Eguchi
Journal:  Braz J Med Biol Res       Date:  2000-06       Impact factor: 2.590

7.  Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats.

Authors:  S Ito; K Komatsu; K Tsukamoto; A F Sved
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

8.  Differential effects of angiotensin II on cardiorespiratory reflexes mediated by nucleus tractus solitarii - a microinjection study in the rat.

Authors:  J F Paton; S Kasparov
Journal:  J Physiol       Date:  1999-11-15       Impact factor: 5.182

9.  Does angiotensin II have a significant tonic action on cardiovascular neurons in the rostral and caudal VLM?

Authors:  P D Potts; A M Allen; J Horiuchi; R A Dampney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

10.  Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats.

Authors:  P D Senanayake; A Moriguchi; H Kumagai; D Ganten; C M Ferrario; K B Brosnihan
Journal:  Peptides       Date:  1994       Impact factor: 3.750

View more
  84 in total

1.  The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase.

Authors:  Erin G Rosenbaugh; James W Roat; Lie Gao; Rui-Fang Yang; Devika S Manickam; Jing-Xiang Yin; Harold D Schultz; Tatiana K Bronich; Elena V Batrakova; Alexander V Kabanov; Irving H Zucker; Matthew C Zimmerman
Journal:  Biomaterials       Date:  2010-04-07       Impact factor: 12.479

2.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Eric Lazartigues; Joseph Francis
Journal:  Cardiovasc Res       Date:  2011-09-27       Impact factor: 10.787

3.  Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure.

Authors:  Juan Gao; Irving H Zucker; Lie Gao
Journal:  Am J Hypertens       Date:  2014-03-31       Impact factor: 2.689

4.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

5.  The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance.

Authors:  Justin L Grobe; Connie L Grobe; Terry G Beltz; Scott G Westphal; Donald A Morgan; Di Xu; Willem J de Lange; Huiping Li; Koji Sakai; Daniel R Thedens; Lisa A Cassis; Kamal Rahmouni; Allyn L Mark; Alan Kim Johnson; Curt D Sigmund
Journal:  Cell Metab       Date:  2010-11-03       Impact factor: 27.287

6.  Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure?

Authors:  Yang Yu; Shun-Guang Wei; Zhi-Hua Zhang; Elise Gomez-Sanchez; Robert M Weiss; Robert B Felder
Journal:  Hypertension       Date:  2008-01-28       Impact factor: 10.190

7.  Human brain contains a novel non-AT1, non-AT2 binding site for active angiotensin peptides.

Authors:  Vardan T Karamyan; Craig A Stockmeier; Robert C Speth
Journal:  Life Sci       Date:  2008-07-22       Impact factor: 5.037

8.  Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases.

Authors:  Jimmy Delaney; Roselynn Chiarello; David Villar; Umadevi Kandalam; Ana Maria Castejon; Michelle A Clark
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

9.  Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence.

Authors:  Jiao-Lin Zheng; Guang-Ze Li; Shu-Zhen Chen; Jin-Ju Wang; James E Olson; Hui-Jing Xia; Eric Lazartigues; Yu-Lan Zhu; Yan-Fang Chen
Journal:  CNS Neurosci Ther       Date:  2014-03-02       Impact factor: 5.243

10.  Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current.

Authors:  Jing-Xiang Yin; Rui-Fang Yang; Shumin Li; Alex O Renshaw; Yu-Long Li; Harold D Schultz; Matthew C Zimmerman
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-20       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.